The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Book
AHRMM's Policies and Procedures Manual for the Health Care Supply Chain, 2nd Edition contains over 160 new and revised health care supply chain…
e-Learning
Explore the role of MMIS and ERP systems in health care, the importance of supply chain data standards and the benefits of EDI for seamless…
Courses
This course expands on the key strategies to improve processes for organizational performance and customer satisfaction.
Courses
This course explores the role of leaders in developing effective teams that meet both functional and organizational goals in recruiting, developing…
Courses
This course explores the role of leaders in developing effective teams that meet both functional and organizational goals in recruiting, developing…
Courses
This course outlines the role of leaders in building a culture of continual improvement and provides guidance on how to achieve it.